Home/Filings/4/0001628280-24-034830
4//SEC Filing

McCarthy Brian Clark 4

Accession 0001628280-24-034830

CIK 0001448431other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 5:22 PM ET

Size

8.1 KB

Accession

0001628280-24-034830

Insider Transaction Report

Form 4
Period: 2024-08-02
McCarthy Brian Clark
Chief Revenue Officer
Transactions
  • Award

    Stock Option

    2024-08-02+18,67718,677 total
    Exercise: $10.49From: 2025-08-02Exp: 2027-08-02Common Stock (18,677 underlying)
  • Award

    Restricted Stock Units

    2024-08-02+9,5339,533 total
    From: 2025-08-02Exp: 2027-08-02Common Stock (9,533 underlying)
Footnotes (2)
  • [F1]The Stock Option will vest 1/3 at the end of each anniversary from issuance.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0002031237

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:22 PM ET
Size
8.1 KB